Future of Pharmaceuticals
A Nonlinear Analysis
Before now, biological systems could only be expressed in terms of linear relationships, however, as knowledge grows and new
techniques of analysis on biological systems is made available, we are realizing the non-linearity of these systems. Les mer
- Vår pris
- 1688,-
(Paperback)
Fri frakt!
Leveringstid:
Sendes innen 7 virkedager
Paperback
Legg i
Paperback
Legg i
Vår pris:
1688,-
(Paperback)
Fri frakt!
Leveringstid:
Sendes innen 7 virkedager
Before now, biological systems could only be expressed in terms of linear relationships, however, as knowledge grows and new
techniques of analysis on biological systems is made available, we are realizing the non-linearity of these systems. The concepts
and techniques of nonlinear analysis allow for more realistic and accurate models in science. The Future of Pharmaceuticals:
A Nonlinear Analysis provides an opportunity to understand the non-linearity of biological systems and its application in
various areas of science, primarily pharmaceutical sciences. This book will benefit professionals in pharmaceutical industries,
academia, and policy who are interested in an entirely new approach to how we will treat disease in the future.
Key Features:
Addresses a new approach of nonlinear analysis.
Applies a theory of projection to chalk out the future, instead of basing on linear evolution. Provides an opportunity to better understand the non-linearity in biological systems and its applications in various areas of science, primarily pharmaceutical sciences.
Helps change the thought process for those looking for answers to their questions which they do not find in the linear relationship approach.
Encourages a broader perspective for the creative process of drug development.
Key Features:
Addresses a new approach of nonlinear analysis.
Applies a theory of projection to chalk out the future, instead of basing on linear evolution. Provides an opportunity to better understand the non-linearity in biological systems and its applications in various areas of science, primarily pharmaceutical sciences.
Helps change the thought process for those looking for answers to their questions which they do not find in the linear relationship approach.
Encourages a broader perspective for the creative process of drug development.
- FAKTA
-
Utgitt:
2022
Forlag: CRC Press
Innbinding: Paperback
Språk: Engelsk
Sider: 568
ISBN: 9780367701390
Format: 25 x 18 cm
- KATEGORIER:
- VURDERING
-
Gi vurdering
Les vurderinger
Preface
Glossary of Terms
Chapter 1 Understanding Nonlinearity
Chapter 2 Evolution of Pharmaceuticals
Chapter 3 Artificial Intelligence
Chapter 4 Drug Discovery Trends
Chapter 5 Drug Development Assays
Chapter 6 Nanotechnology
Chapter 7 Antimicrobials
Chapter 8 Therapeutic Proteins
Chapter 9 Manufacturing Trends
Chapter 10 Therapeutic Proteins Delivery Systems
Chapter 11 Gene and Cell Therapy
Chapter 12 Nucleic Acid Vaccines
Chapter 13 Botanical Products
Chapter 14 Regulatory Optimization
Chapter 15 Intellectual Property
Glossary of Terms
Chapter 1 Understanding Nonlinearity
Chapter 2 Evolution of Pharmaceuticals
Chapter 3 Artificial Intelligence
Chapter 4 Drug Discovery Trends
Chapter 5 Drug Development Assays
Chapter 6 Nanotechnology
Chapter 7 Antimicrobials
Chapter 8 Therapeutic Proteins
Chapter 9 Manufacturing Trends
Chapter 10 Therapeutic Proteins Delivery Systems
Chapter 11 Gene and Cell Therapy
Chapter 12 Nucleic Acid Vaccines
Chapter 13 Botanical Products
Chapter 14 Regulatory Optimization
Chapter 15 Intellectual Property
Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and University of
Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field
of bioprocessing, drug discovery, mRNA vaccines, drug formulations, thermodynamic systems, alcohol
aging, nutraceuticals and treatment of autoimmune diseases. He has established multiple biotechnology
projects, from concept to market. He also serves as an advisor to major pharmaceutical and biopharmaceutical
companies, regulatory agencies, the FDA, the US Congress, and several heads of state. He is
also a patent law practitioner.
Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field
of bioprocessing, drug discovery, mRNA vaccines, drug formulations, thermodynamic systems, alcohol
aging, nutraceuticals and treatment of autoimmune diseases. He has established multiple biotechnology
projects, from concept to market. He also serves as an advisor to major pharmaceutical and biopharmaceutical
companies, regulatory agencies, the FDA, the US Congress, and several heads of state. He is
also a patent law practitioner.